Menu
GeneBe

SGCG

sarcoglycan gamma

Basic information

Region (hg38): 13:23180978-23325162

Previous symbols: [ "DMDA1", "MAM", "LGMD2C" ]

Links

ENSG00000102683NCBI:6445OMIM:608896HGNC:10809Uniprot:Q13326AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive limb-girdle muscular dystrophy type 2C (Definitive), mode of inheritance: AR
  • autosomal recessive limb-girdle muscular dystrophy type 2C (Strong), mode of inheritance: AR
  • autosomal recessive limb-girdle muscular dystrophy type 2C (Supportive), mode of inheritance: AR
  • autosomal recessive limb-girdle muscular dystrophy type 2C (Definitive), mode of inheritance: AR
  • autosomal recessive limb-girdle muscular dystrophy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Muscular dystrophy, limb-girdle, limb-girdle, autosomal recessive, 5ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingMusculoskeletal1303286; 7481775; 8923014; 8968757; 10507732; 10720277; 16832103; 18285821

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SGCG gene.

  • Autosomal recessive limb-girdle muscular dystrophy type 2C (368 variants)
  • not provided (154 variants)
  • Sarcoglycanopathy (38 variants)
  • not specified (36 variants)
  • Limb-Girdle Muscular Dystrophy, Recessive (20 variants)
  • Charlevoix-Saguenay spastic ataxia (6 variants)
  • Autosomal recessive limb-girdle muscular dystrophy (4 variants)
  • Inborn genetic diseases (3 variants)
  • - (2 variants)
  • Abnormality of the musculature (1 variants)
  • Primary dilated cardiomyopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SGCG gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
71
clinvar
2
clinvar
77
missense
2
clinvar
3
clinvar
124
clinvar
2
clinvar
1
clinvar
132
nonsense
10
clinvar
9
clinvar
1
clinvar
20
start loss
0
frameshift
21
clinvar
18
clinvar
39
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
3
clinvar
16
clinvar
2
clinvar
21
splice region
1
10
16
2
29
non coding
8
clinvar
65
clinvar
36
clinvar
109
Total 36 46 141 138 39

Highest pathogenic variant AF is 0.000158

Variants in SGCG

This is a list of pathogenic ClinVar variants found in the SGCG region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
13-23180988-G-A Limb-Girdle Muscular Dystrophy, Recessive • Sarcoglycanopathy Benign/Likely benign (Nov 19, 2019)311478
13-23181070-T-C Sarcoglycanopathy • Limb-Girdle Muscular Dystrophy, Recessive • not specified • SGCG-related disorder Conflicting classifications of pathogenicity (Mar 01, 2024)311479
13-23181080-G-A Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Apr 13, 2022)2416024
13-23181294-T-C Likely benign (May 24, 2021)1326619
13-23203416-A-T Likely benign (Sep 04, 2018)1193684
13-23203451-T-G Likely benign (Sep 05, 2018)1206684
13-23203521-A-C Likely benign (Sep 05, 2018)1188460
13-23203603-C-T Likely benign (Sep 05, 2018)1201163
13-23203687-C-T not specified Conflicting classifications of pathogenicity (Feb 04, 2016)283890
13-23203692-C-T Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Nov 10, 2021)805445
13-23203699-T-C Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Aug 03, 2022)1714973
13-23203701-C-T Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Jul 15, 2022)597795
13-23203702-G-A Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Oct 13, 2022)284971
13-23203704-G-T Autosomal recessive limb-girdle muscular dystrophy type 2C Likely pathogenic (Oct 24, 2023)2678704
13-23203711-A-G Autosomal recessive limb-girdle muscular dystrophy type 2C • Sarcoglycanopathy Uncertain significance (Mar 05, 2023)291214
13-23203716-A-G Autosomal recessive limb-girdle muscular dystrophy type 2C • Inborn genetic diseases Uncertain significance (Sep 01, 2022)530808
13-23203721-C-T Autosomal recessive limb-girdle muscular dystrophy type 2C Likely benign (Feb 01, 2022)2045276
13-23203728-G-A Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Apr 02, 2019)597559
13-23203732-T-A Inborn genetic diseases Uncertain significance (Aug 28, 2023)2622161
13-23203736-C-T Autosomal recessive limb-girdle muscular dystrophy type 2C Likely benign (Jan 27, 2024)1637084
13-23203738-T-C Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Jun 02, 2021)1505018
13-23203739-A-G Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Aug 05, 2021)1438583
13-23203740-G-C Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Mar 08, 2022)2077176
13-23203751-G-A Autosomal recessive limb-girdle muscular dystrophy type 2C Likely benign (Sep 19, 2023)2761856
13-23203751-G-T Autosomal recessive limb-girdle muscular dystrophy type 2C Uncertain significance (Aug 31, 2022)862021

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SGCGprotein_codingprotein_codingENST00000218867 7144214
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00004820.8761257050431257480.000171
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1341681631.030.000008741881
Missense in Polyphen6465.2140.98139773
Synonymous-1.147361.61.180.00000359562
Loss of Function1.44915.00.6007.03e-7180

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006670.000666
Ashkenazi Jewish0.00009920.0000992
East Asian0.00005440.0000544
Finnish0.00009240.0000924
European (Non-Finnish)0.0001930.000193
Middle Eastern0.00005440.0000544
South Asian0.00009890.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix.;
Pathway
Dilated cardiomyopathy (DCM) - Homo sapiens (human);Viral myocarditis - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Arrhythmogenic Right Ventricular Cardiomyopathy (Consensus)

Recessive Scores

pRec
0.363

Intolerance Scores

loftool
0.314
rvis_EVS
-0.14
rvis_percentile_EVS
43.77

Haploinsufficiency Scores

pHI
0.111
hipred
N
hipred_score
0.390
ghis
0.481

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0893

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sgcg
Phenotype
growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype;

Gene ontology

Biological process
muscle organ development;cardiac muscle tissue development;heart contraction
Cellular component
nucleoplasm;cytoplasm;cytoskeleton;plasma membrane;sarcoglycan complex;integral component of membrane;sarcolemma
Molecular function
protein binding